Congratulations Mina Zeinali for receiving the 2021-22 Chemical Engineering Staff Incentive Award!

Congratulations Mina, well deserved!

Congratulations Dr. Yoontae Kang for receiving the 2021 Biointerfaces Institute Innovation Award!

Congratulations Yoontae, wonderful recognition of your hardwork!

Congraulations to Lab Alumni Dr. Owens for her Pilot Study publication in Biomedicines

Synergistic Analysis of Circulating Tumor Cells Reveals Prognostic Signatures in Pilot Study of Treatment-Naive Metastatic Pancreatic Cancer Patients

Congraulations to Lab Alumni Dr. Owens and Dr. Purcell for their compelling publication in Frontiers!

Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer

Dr. Emma Purcell successfully defends her thesis and accepts position as a Postdoctoral Research Fellow at Stanford University!

May 2021: Congratulations Dr. Purcell!

Dr. Kaylee Smith successfully defends her thesis and accepts position at Astrin Bioscience in Minneapolis, Minnesota!

May 2021: Congratulations Dr. Smith!

Dr. Sarah Owen featured by the UM Center for RNA Biomedicine

January 2021, Dr. Owen tells her story through grad school and beyond after landing dream job

Dr. Owen published several impactful papers in the field of RNA for cancer monitoring through her career at Michigan. After taking an internship at Seagen in college, Dr. Owen has wanted to return to the Seattle area to continue her work at Seagen. Dr. Owen will apply her knowledge of RNA gained at Michigan to her new job.

Dr. Sarah Owen successfully defends her thesis and accepts position at Seagen in Seattle, Washington!

December 2020: Congratulations Dr. Owen!

Dr. Yoon-Tae Kang leads and a team of researchers develop dual-utilication OncoBean (DUO) microfluidic device to isolate and characterize circulating tumor cells and exosomes from melanoma patients

August 2020: The work by Dr. Kang was featured in Exosome RNA

Dr. Yoon-Tae's team developed a novel microfluidic technology to dual-isolate circulating tumor cells from patients with melanoma cancer. They found higher levels of exosomes in the patient cohort and use RT-qPCR to show mRNA differences between CTCs and exosomes compared to healthy donors.

Dr. Yoon-Tae Kang and Thomad Hadlock develop a microfluidic technoly to isolate and characterize exosomes

August 2020: The work by Dr. Kang was featured in Exosome RNA

Dr. Yoon-Tae and Thomas Hadlock developed a novel microfluidic technology to isolate exosomes from the plasma of cancer patients. These exosomes can then be profiled to inform clinician's about a patient's cancer.